A simplified public tender offer for outstanding shares of French medical device company VEXIM was completed by Stryker, giving the company 92.19% of VEXIM's share capital. Stryker now holds about 8.4 million VEXIM shares, as well as 91.56% of VEXIM's voting rights.

Avoid Costly Mistakes When Automating Your QMSAutomating your quality management system will transform your path to compliance with FDA, ISO, and GxP. This white paper with companion checklist explores the benefits of a centralized QMS + common pitfalls and best practices when expanding or transitioning to automated quality management. DOWNLOAD NOW.

LSP, a life sciences investment group based in the Netherlands, closed its LSP Health Economics Fund 2 at $330 million. The fund seeks to make investments in about 15 medical device, digital health and diagnostics companies whose products have a strong health economics proposition, a potential for fast adoption and can lower health care costs and improve patient outcomes.

NuVasive agreed to pay an undisclosed amount for SafePassage, a provider of intraoperative neurophysiological monitoring services. The acquisition is expected to complement the NuVasive Clinical Services' geographical footprint, as well as advance the services business growth and enable the company to reach key strategic markets and increase significant coverage.

A round of Series B financing brought in $18 million for Lincoln, Neb.-based Virtual Incision, which makes a miniaturized robotically assisted surgical device for less-invasive general surgery abdominal procedures. The company intends to use the proceeds for 510(k) premarket notification submission to the FDA for its next-generation device.

Health and wellness company Thorne Research will use a device developed by Drawbridge Health, a GE Ventures spinoff, to draw blood and chemically stabilize it for transport. Thorne develops personalized diet, exercise and supplement plans based on the results of blood biomarker tests, and its WellnessFX offers an app for scheduling blood, genetic and microbiome tests.

Teleflex agreed to provide HealthTrust with respiratory heaters and accessories under a group purchasing deal that took effect Dec. 1. The agreement gives over 400 HealthTrust member hospitals access to Teleflex's humidification products, including the Comfort Flo plus high-flow nasal cannula and the Hudson RCI Neptune heated humidifier.

European regulators gave Germany-based Senzime CE mark approval for its TetraGraph neuromuscular monitor, which is intended for facilitating perioperative physiologic data monitoring in surgical patients who receive neuromuscular blocking drugs for general anesthesia and muscle relaxation. The system measures, analyzes and displays muscle function through peripheral nerve stimulation.

A pediatric-specific wrist fusion plate system was launched by OrthoPediatrics. The system, which is part of the company's PediFrag brand, uses low-profile, stainless steel plates with two implant lengths to reduce soft tissue irritation and minimize plate prominence.

A bill was introduced by some members of the House Ways and Means Committee on Tuesday to extend the suspension of the medical device tax for another five years. AdvaMed President and CEO Scott Whitaker commended the move and called for the immediate adoption of the suspension, saying that "it is only a first step toward the ultimate goal to fully repeal the medical device tax."

Think Surgical's TSolution One Surgical System, a surgical robot that facilitates total knee arthroplasty, was granted CE mark approval by European regulators. The system, which allows for the use of 3D planning and an implant library to create a personalized presurgical joint replacement plan for a patient, prepares the bone cavity and joint surface and removes the diseased bone.

Dec. 14 | 1-2 p.m. EST The Medical Device Regulation (MDR) is now a reality, having been published for final review. Medical device manufacturers, suppliers and other service providers will be affected by the regulation. Companies will need to assess their current operations documents and standard operating procedures and develop a plan for complying with the new MDR requirements. While documents, training and supplier management will become more critical, postmarket surveillance programs will be even more of a concern. This webinar will examine some of the more pervasive changes, as well as the new chapters and other additions. Attendees will also learn how his/her company will need to change or update its current quality systems and processes to comply with the new requirements.

The AdvaMed Purchasing Group is a new member-only benefit that helps companies purchase the very best goods and services from nationally recognized suppliers at the very best cost, using a trusted and proven vetting system and the collective purchasing power of our membership. Participation is free for AdvaMed members, and there are no minimum commitments. Get started today.

There is no greater mistake than to try to leap an abyss in two jumps.